Sex-Specific Outcomes After Anterior Cruciate Ligament Reconstruction Using an All-Soft Tissue Quadriceps Tendon Autograft in a Young Active Population.

التفاصيل البيبلوغرافية
العنوان:	Sex-Specific Outcomes After Anterior Cruciate Ligament Reconstruction Using an All-Soft Tissue Quadriceps Tendon Autograft in a Young Active Population.
المؤلفون:	Petit CB; Emory Sports Performance And Research Center, Flowery Branch, Georgia, USA.; Emory Sports Medicine Center, Atlanta, Georgia, USA.; Department of Orthopaedics, Emory University School of Medicine, Atlanta, Georgia, USA.; Medical College of Georgia, Augusta, Georgia, USA., Slone HS; Department of Orthopaedics and Physical Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Diekfuss JA; Emory Sports Performance And Research Center, Flowery Branch, Georgia, USA.; Emory Sports Medicine Center, Atlanta, Georgia, USA.; Department of Orthopaedics, Emory University School of Medicine, Atlanta, Georgia, USA., Barber Foss KD; Emory Sports Performance And Research Center, Flowery Branch, Georgia, USA.; Emory Sports Medicine Center, Atlanta, Georgia, USA.; Department of Orthopaedics, Emory University School of Medicine, Atlanta, Georgia, USA., Warren SM; Emory Sports Performance And Research Center, Flowery Branch, Georgia, USA.; Emory Sports Medicine Center, Atlanta, Georgia, USA.; Department of Orthopaedics, Emory University School of Medicine, Atlanta, Georgia, USA., Montalvo AM; Emory Sports Performance And Research Center, Flowery Branch, Georgia, USA.; College of Health Solutions, Arizona State University, Phoenix, Arizona, USA., Lamplot JD; Emory Sports Performance And Research Center, Flowery Branch, Georgia, USA.; Campbell Clinic Orthopaedics, Germantown, Tennessee, USA., Myer GD; Emory Sports Performance And Research Center, Flowery Branch, Georgia, USA.; Emory Sports Medicine Center, Atlanta, Georgia, USA.; Department of Orthopaedics, Emory University School of Medicine, Atlanta, Georgia, USA.; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia, USA.; The Micheli Center for Sports Injury Prevention, Waltham, Massachusetts, USA.; Youth Physical Development Centre, Cardiff Metropolitan University, Cardiff, UK., Xerogeanes JW; Emory Sports Performance And Research Center, Flowery Branch, Georgia, USA.; Emory Sports Medicine Center, Atlanta, Georgia, USA.; Department of Orthopaedics, Emory University School of Medicine, Atlanta, Georgia, USA.
المصدر:	The American journal of sports medicine [Am J Sports Med] 2024 Aug; Vol. 52 (10), pp. 2450-2455. Date of Electronic Publication: 2024 Aug 03.
نوع المنشور:	Journal Article
اللغة:	English
بيانات الدورية:	Publisher: Sage Publications Country of Publication: United States NLM ID: 7609541 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-3365 (Electronic) Linking ISSN: 03635465 NLM ISO Abbreviation: Am J Sports Med Subsets: MEDLINE
أسماء مطبوعة:	Publication: 2004- : Thousand Oaks, CA : Sage Publications Original Publication: Baltimore, Williams & Wilkins.
مواضيع طبية MeSH:	Anterior Cruciate Ligament Reconstruction/methods , Anterior Cruciate Ligament Injuries/surgery , Return to Sport* , Quadriceps Muscle/transplantation , Autografts , Reinjuries* , Tendons*/transplantation, Humans ; Male ; Female ; Adolescent ; Young Adult ; Sex Factors ; Transplantation, Autologous ; Retrospective Studies
مستخلص:	Background: The ideal graft for anterior cruciate ligament (ACL) reconstruction (ACLR) in young athletes has a high return-to-sport (RTS) rate and a low reinjury rate. Quadriceps tendon autografts are being used with increasing frequency for ACLR in this population, despite a paucity of evidence to support their use. Purpose: To report the RTS rate, ipsilateral reinjury rate, and contralateral ACL injury rate in a young athletic population undergoing primary ACLR using an all-soft tissue quadriceps tendon (ASTQT) autograft. Study Design: Cases series; Level of evidence, 4. Methods: Patients aged 14 to 22 years who underwent primary ACLR using an ASTQT autograft by a single surgeon between January 1, 2005, and April 30, 2020, were identified via electronic medical records and contacted ≥24 months after ACLR to complete a survey regarding subsequent ipsilateral or contralateral ACL injuries and RTS. Patients who had undergone previous ACLR (ipsilateral or contralateral) were excluded. Results: A total of 656 patients (330 male, 326 female; mean age, 17.9 years) were identified, and 395 patients completed the survey (60.2%; 174 male, 221 female; mean age, 17.8 years) with a mean follow-up of 73 ± 29 months (range, 24-139 months). The RTS rate was high (male: 87.7%; female: 82.8%; P = .19). Male and female patients had similar rates of revision ACLR (male: 12.6%; female: 10.0%; P = .40) and contralateral ACL injuries (male: 13.8%; female: 11.3%; P = .46). Conclusion: A high RTS rate and similar rates of ipsilateral and contralateral ACL injuries were found for male and female patients in a young athletic population undergoing primary ACLR using an ASTQT autograft. These results help one to better understand the utility of ASTQT grafts to support successful ACLR in young athletic populations, for which ASTQT grafts appear to yield favorable outcomes. Competing Interests: One or more of the authors has declared the following potential conflict of interest or source of funding: H.S. has received support for education from Peerless Surgical and Evolution Surgical and travel expenses from Arthrex. J.D.L. has received hospitality payments from Arthrex and Smith and Nephew; consulting fees from DePuy Synthes; and education payments from United Orthopedics, Smith and Nephew, and Elite Orthopedics. G.D.M. consults with commercial entities to support applications to the United States Food and Drug Administration but has no financial interest in the commercialization of the products; his institution receives current and ongoing grant funding from the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (grants U01AR067997, R01AR070474, R01AR055563, R01AR076153, R01AR077248) and has received industry-sponsored research funding related to brain injury prevention and assessments from Q30 Innovations and ElMindA; receives author royalties from Human Kinetics and Wolters Kluwer; and is an inventor of biofeedback technologies (patent No. US11350854B2; Augmented and Virtual Reality for Sport Performance and Injury Prevention Application [approved June 7, 2022]) designed to enhance rehabilitation and prevent injuries and receives royalties or licensing fees. J.W.X. has received consulting fees from Arthrex and Trice Medical, has received compensation for services other than consulting from Arthrex, has received royalties or licensing fees from Arthrex, has received support for education from United Orthopedics, and holds stock or stock options in my-eye. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.
فهرسة مساهمة:	Keywords: ACL; athlete; pediatric; quadriceps tendon autograft; reinjury; return to sport; young adult
تواريخ الأحداث:	Date Created: 20240804 Date Completed: 20240822 Latest Revision: 20240822
رمز التحديث:	20240822
DOI:	10.1177/03635465241262018
PMID:	39097771
قاعدة البيانات:	MEDLINE

Full Text Finder

الوصف
تدمد:	1552-3365
DOI:	10.1177/03635465241262018